Kindly MD, Inc. (KDLY) Stock Analysis
DELISTED 2025
What happened to Kindly MD, Inc. (KDLY) stock?
Kindly MD, Inc. (KDLY) no longer trades on public markets. It was delisted in May 2025. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Kindly MD, Inc. (KDLY) trades at $11.30. Kindly MD, Inc. provides direct healthcare services, integrating prescription medicine and behavioral health. Market cap: $68.1M, Sector: Healthcare.
Last analyzed: Mar 17, 2026Analyst Coverage for KDLY: KDLY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates KDLY against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
Kindly MD, Inc. (KDLY) Healthcare & Pipeline Overview
Kindly MD, Inc. offers integrated healthcare services, combining prescription medicine and behavioral health, operating on a subscription and fee-for-service model. The company focuses on specialty outpatient clinical services, differentiating itself through personalized and integrated care in the evolving healthcare landscape, yet faces challenges in profitability.
What Is the Investment Thesis for KDLY?
Kindly MD, Inc. presents a unique investment proposition within the healthcare sector, focusing on integrated prescription medicine and behavioral health services. The company's high gross margin of 98.8% indicates strong pricing power and efficient service delivery. However, the company's negative P/E ratio of -0.02 and a significantly negative profit margin of -4569.5% raise concerns about its current profitability and operational efficiency. Growth catalysts include expanding its subscription-based services and scaling its online retail of healthcare products. Investors should closely monitor the company's ability to achieve profitability and manage its operational costs effectively. The company's beta of -0.90 suggests a potential buffer against market volatility, but the overall financial health needs improvement to justify a strong investment case.
Based on FMP financials and quantitative analysis
KDLY Key Highlights
Market capitalization of $68.1M indicates a small-cap company with potential for growth but also higher risk.
- P/E ratio of -0.02 reflects current losses, suggesting the company is not yet profitable.
- Gross margin of 98.8% demonstrates strong pricing power and efficient service delivery.
- Profit margin of -4569.5% indicates significant operational inefficiencies and high costs relative to revenue.
- Beta of -0.90 suggests the stock is less volatile than the market, potentially offering some downside protection.
Who Are KDLY's Competitors?
KDLY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AKYA Akoya Biosciences, Inc. | $1.29 | -5.15% | $64.4M | 50 |
| DRRX DURECT Corporation | $1.91 | -1.04% | $59.3M | 50 |
| LABP Landos Biopharma, Inc. | $22.93 | +0.57% | $71.7M | — |
| LFWD Lifeward Ltd. | $7.33 | +0.83% | $11.8M | 45 |
| LIEN Chicago Atlantic BDC, Inc. | $9.74 | +2.53% | $223M | 88 |
| NEUE NeueHealth, Inc. | $6.75 | +0.00% | $60.9M | 42 |
| PARK Park Dental Partners, Inc. | $21.68 | +2.26% | $97.9M | 38 |
| NAKA Kindly MD, Inc. | $6.30 | +3.96% | $110M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are KDLY's Key Strengths?
Integrated healthcare service offering.
- High gross margin (98.8%).
- Focus on subscription-based revenue.
- Data collection and research capabilities.
What Are KDLY's Weaknesses?
Negative profit margin (-4569.5%).
- Reliance on a small team of 23 employees.
- Limited brand recognition.
- Small market capitalization ($0.07 billion).
What Could Drive KDLY Stock Higher?
Expansion of subscription-based services to new markets.
- Data collection and research initiatives to improve patient outcomes.
- Launch of new online healthcare products.
- Strategic partnerships with healthcare providers.
What Are the Key Risks for KDLY?
Financial-distress signal — its Altman Z-Score of -2.63 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-84.8%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Regulatory changes affecting the healthcare industry.
- Intense competition from established healthcare providers.
- Economic downturn impacting consumer spending on healthcare.
- Cybersecurity threats and data privacy concerns.
What Are the Growth Opportunities for KDLY?
- Expansion of Subscription-Based Services: Kindly MD can grow by expanding its subscription-based service offerings, providing recurring revenue and fostering long-term customer relationships. The market for subscription-based healthcare services is projected to reach $220 billion by 2028, driven by increasing demand for convenient and personalized healthcare solutions. By focusing on chronic pain management and mental health subscriptions, Kindly MD can capture a significant share of this growing market.
- Scaling Online Retail of Healthcare Products: Kindly MD has the opportunity to scale its online retail operations, offering a wider range of healthcare products and leveraging e-commerce platforms to reach a broader customer base. The global e-pharmacy market is expected to reach $177.8 billion by 2026, presenting a significant growth opportunity for Kindly MD. Strategic partnerships with suppliers and effective online marketing can drive sales and increase revenue.
- Geographic Expansion: Kindly MD can expand its physical presence by opening new clinics in underserved areas, increasing access to its integrated healthcare services. The demand for outpatient clinical services is growing, particularly in rural and suburban areas, driven by increasing healthcare costs and a shortage of primary care physicians. By strategically locating new clinics, Kindly MD can tap into new markets and increase its patient base.
- Strategic Partnerships with Healthcare Providers: Forming strategic partnerships with hospitals, clinics, and other healthcare providers can expand Kindly MD's reach and integrate its services into existing healthcare systems. Collaborative care models are becoming increasingly popular, driven by the need for coordinated and comprehensive patient care. By partnering with established healthcare providers, Kindly MD can gain access to new patient populations and enhance its reputation.
- Data Collection and Research Initiatives: Kindly MD's data collection and research efforts can be leveraged to develop new insights into patient behavior, treatment outcomes, and healthcare trends. The market for healthcare analytics is projected to reach $34.4 billion by 2027, driven by the increasing availability of healthcare data and the need for data-driven decision-making. By investing in data analytics capabilities, Kindly MD can improve its service offerings, personalize patient care, and identify new growth opportunities.
What Are KDLY's Competitive Advantages?
- Integrated Service Offering: Combines prescription medicine and behavioral health, providing a holistic approach to patient care.
- Subscription-Based Revenue: Recurring revenue stream from subscription-based services.
- Data Collection and Research: Proprietary data insights for personalized care and service improvement.
What Does KDLY Do?
Kindly MD, Inc., established in 2019 and based in Salt Lake City, Utah, operates as a healthcare and healthcare data company. Originally named Utah Therapeutic Health Center, LLC, the company rebranded to Kindly MD, Inc. in March 2022. Kindly MD provides direct healthcare services to patients, integrating prescription medicine and behavioral health services. The company's core offering revolves around specialty outpatient clinical services, delivered through a subscription and fee-for-service model, designed to augment traditional healthcare. Kindly MD's services encompass a broad spectrum of evaluation and management offerings, including chronic pain management, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy. In addition to clinical services, Kindly MD engages in data collection and research, and provides online and email campaign marketing services. The company also participates in the retail sale of healthcare products through its clinics and online platform. Kindly MD aims to provide accessible and integrated healthcare solutions, focusing on personalized care and leveraging data-driven insights to improve patient outcomes.
What Products and Services Does KDLY Offer?
- Provides direct healthcare services to patients.
- Integrates prescription medicine and behavioral health services.
- Offers specialty outpatient clinical services on a subscription and fee-for-service basis.
- Provides evaluation and management services for chronic pain, functional medicine, and mental health.
- Engages in data collection and research to improve patient outcomes.
- Offers online and email campaign marketing services.
- Sells healthcare products through clinics and online.
How Does KDLY Make Money?
- Subscription-based services for ongoing healthcare management.
- Fee-for-service model for individual consultations and treatments.
- Retail sales of healthcare products through clinics and online.
- Data collection and research services for healthcare insights.
What Industry Does KDLY Operate In?
Kindly MD, Inc. operates within the evolving medical equipment and services industry, which is experiencing growth driven by technological advancements, increasing demand for personalized healthcare, and a growing aging population. The industry is characterized by intense competition, with established players like AKYA, DRRX, LABP, LFWD, and LIEN vying for market share. Kindly MD's focus on integrated behavioral and prescription medicine positions it to capitalize on the trend towards holistic healthcare solutions. However, the company must navigate regulatory hurdles and adapt to changing reimbursement models to remain competitive.
Who Are KDLY's Key Customers?
- Individuals seeking integrated healthcare solutions.
- Patients with chronic pain, mental health issues, and addiction.
- Healthcare providers seeking data-driven insights.
- Consumers purchasing healthcare products online.
Company Profile
Kindly MD, Inc. operates in the Medical - Equipment & Services industry within the Healthcare sector. It is headquartered in Salt Lake City, US. The company is led by CEO Timothy Pickett. KDLY has traded publicly since 2024.
Financial Health
Kindly MD, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -2.63 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on equity for Kindly MD, Inc. stands at -84.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -46.7%, showing how much profit it generates from its asset base. Its free cash flow yield is -65.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.25 means current liabilities exceed short-term assets, a liquidity point worth watching.
KDLY Valuation & Market Position
With a $68.1M market cap, Kindly MD, Inc. sits in the micro-cap segment of the market.
Insider Activity
The most recent 7 insider filings for Kindly MD, Inc. break down as 0 sales and 7 purchases. On net that is roughly 16K shares acquired (about $26K) — insiders putting money in tends to read as conviction.
KDLY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future, indicating that key stakeholders believe in its growth potential.
- Community sentiment has turned increasingly positive, with discussions highlighting the company's innovative approach to healthcare solutions.
- Recent partnerships announced have garnered attention, positioning Kindly MD as a forward-thinking player in the telehealth space.
- Market perception has shifted favorably, with analysts noting the potential for expansion in a rapidly growing industry.
Bear Case
- Concerns have been raised about the company's ability to scale operations effectively, which may hinder long-term growth prospects.
- Some community members express skepticism regarding the sustainability of recent hype, fearing it may not translate into lasting performance.
- Recent regulatory discussions in the telehealth industry have created uncertainty, leading to cautious sentiment among investors.
- Competition in the telehealth sector is intensifying, with established players threatening Kindly MD's market share and growth trajectory.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
KDLY Latest News
No recent news available for KDLY.
Leadership: Timothy Pickett
CEO
Timothy Pickett is the CEO of Kindly MD, Inc., managing a team of 23 employees. His background includes experience in healthcare management and operations. He has a proven track record of leading and scaling healthcare organizations. Pickett's expertise lies in developing and implementing strategies to improve patient outcomes and drive revenue growth. He is committed to providing accessible and integrated healthcare solutions to patients.
Track Record: Under Timothy Pickett's leadership, Kindly MD, Inc. has focused on integrating prescription medicine and behavioral health services. He has overseen the expansion of the company's specialty outpatient clinical services and the development of its subscription-based model. Pickett has also spearheaded the company's data collection and research initiatives. His strategic decisions have positioned Kindly MD as a provider of personalized and integrated healthcare solutions.
Common Questions About KDLY (Healthcare)
What happened to Kindly MD, Inc. (KDLY) stock?
Kindly MD, Inc. (KDLY) no longer trades on public markets. It was delisted in May 2025. The figures below are historical and are not a current quote.
Can I still buy KDLY shares?
No. KDLY stopped trading on public markets in May 2025, so the shares are not available through a broker. Anything you see quoted for KDLY elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before KDLY stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Kindly MD, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Kindly MD, Inc. do?
Kindly MD, Inc. operates as an integrated healthcare provider, combining prescription medicine and behavioral health services. The company delivers specialty outpatient clinical services through a subscription and fee-for-service model, designed to augment traditional healthcare. Kindly MD offers a range of evaluation and management services, including chronic pain management, functional medicine, cognitive behavioral therapy, and addiction therapy.
What do analysts say about KDLY stock?
Analyst coverage for Kindly MD, Inc. (KDLY) is currently limited, reflecting its small market capitalization and recent operational challenges. Key valuation metrics, such as the negative P/E ratio, indicate that the company is not yet profitable. Growth considerations center on the company's ability to expand its subscription-based services and scale its online retail operations.
What are the main risks for KDLY?
Kindly MD, Inc. faces several key risks, including intense competition within the healthcare industry, which could limit its ability to gain market share. Regulatory changes and compliance requirements pose ongoing challenges, potentially increasing operational costs. The company's negative profit margin (-4569.5%) highlights significant financial risks, requiring substantial improvements in operational efficiency.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- AI analysis is pending and may provide further insights.
- The healthcare industry is subject to regulatory changes and market volatility.